Abstract
Poly(d,l-lactic acid) nanoparticles were freeze-dried in this study. With respect to drying, effect of protective excipients and purification from excess surfactant were evaluated. The nanoparticles were prepared by the nanoprecipitation method with or without a surfactant, poloxamer 188. The particles with the surfactant were used as such or purified by tangential flow filtration. The protective excipients tested were trehalose, sucrose, lactose, glucose, poloxamer 188, and some of their combinations. The best freeze-drying results in terms of nanoparticle survival were achieved with trehalose or sucrose at concentrations 5% and 2% and, on the other hand, with a combination of lactose and glucose. Purification of the nanoparticle dispersion from the excess surfactant prior to the freeze-drying by tangential flow filtration ensured better drying outcome and enabled reduction of the amount of the protective excipients used in the process. The excess surfactant, if not removed, was assumed to interact with the protective excipients decreasing their protective mechanism towards the nanoparticles.
Similar content being viewed by others
References
Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res. 2006;23:1417–50.
Chacón M, Molpeceres J, Berges L, Guzmán M, Aberturas MR. Stability and freeze-drying of cyclosporine loaded poly(d,l-lactide-glycolide) carriers. Eur J Pharm Sci. 1999;8:99–107.
Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58:1688–713.
Abdelwahed W, Degobert G, Fessi H. A pilot study of freeze drying of poly(ɛ-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization. Int J Pharm. 2006;309:178–88.
de Jaeghere F, Allémann E, Leroux J-C, Stevels W, Feijen J, Doelker E, et al. Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm Res. 1999;16:859–66.
Jeong Y-I, Shim Y-H, Kim C, Lim G-T, Choi K-C, Yoon C. Effect of cryoprotectants on the reconstitution properties of surfactant-free nanoparticles of poly(d,l-lactide-co-glycolide). J Microencapsul. 2005;22:593–601.
Konan YN, Gurny R, Allémann E. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm. 2002;233:239–52.
Cavalli R, Caputo O, Carlotti ME, Trotta M, Scarnecchia C, Gasco MR. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int J Pharm. 1997;148:47–54.
Schwarz C, Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm. 1997;157:171–9.
Layre A-M, Couvreur P, Richard J, Requier D, Ghermani NE, Gref R. Freeze-drying of composite core-shell nanoparticles. Drug Dev Ind Pharm. 2006;32:839–46.
Anhorn MG, Mahler H-C, Langer K. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients. Int J Pharm. 2008;363:162–9.
Zillies JC, Zwiorek K, Hoffmann F, Vollmar A, Anchordoquy TJ, Winter G, et al. Formulation development of freeze-dried oligonucleotide-loaded gelatin nanoparticles. Eur J Pharm Biopharm. 2008;70:514–21.
Saez A, Guzmán M, Molpeceres J, Aberturas MR. Freeze-drying of polycaprolactone and poly(d,l-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur J Pharm Biopharm. 2000;50:379–87.
de Chasteigner S, Fessi H, Cavé G, Devissaguet JP, Puisieux F. Gastro-intestinal tolerance study of a freeze-dried oral dosage form of indometacin-loaded nanocapsules. STP Pharma Sci. 1995;5:242–6.
Hirsjärvi S, Peltonen L, Kainu L, Hirvonen J. Freeze-drying of low molecular weight poly(l-lactic acid) nanoparticles: effect of cryo- and lyoprotectants. J Nanosci Nanotechnol. 2006;6:3110–7.
Abdelwahed W, Degobert G, Fessi H. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm. 2006;63:87–94.
Dalwadi G, Sunderland VB. Purification of PEGylated nanoparticles using tangential flow filtration (TFF). Drug Dev Ind Pharm. 2007;33:1030–9.
Dalwadi G, Benson H, Chen Y. Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions. Pharm Res. 2005;22:2152–62.
Limayem I, Charcosset C, Fessi H. Purification of nanoparticle suspensions by a concentration/diafiltration process. Sep Purif Technol. 2004;38:1–9.
de Jaeghere F, Allémann E, Feijen J, Kissel T, Doelker E, Gurny R. Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles. Pharm Dev Technol. 2000;5:473–83.
Hirsjärvi S, Peltonen L, Hirvonen J. Layer-by-layer polyelectrolyte coating of low molecular weight poly(lactic acid) nanoparticles. Colloid Surf B. 2006;49:93–9.
Sukhorukov GB, Donath E, Lichtenfeld H, Knippel E, Knippel M, Budde A, et al. Layer-by-layer self assembly of polyelectrolytes on colloidal particles. Colloid Surf A. 1998;137:253–66.
Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 1989;55:R1–4.
Hirsjärvi S, Peltonen L, Hirvonen J. Surface pressure measurements in particle interaction and stability studies of poly(lactic acid) nanoparticles. Int J Pharm. 2008;348:153–60.
Luzardo MdC, Amalfa F, Nuñez AM, Díaz S, Biondi de Lopez AC, Disalvo EA. Effect of trehalose and sucrose on the hydration and dipole potential of lipid bilayers. Biophys J. 2000;78:2452–8.
Quintanar-Guerrero D, Ganem-Quintanar A, Allémann E, Fessi H, Doelker E. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(d,l-lactic acid) nanoparticles prepared by an emulsion–diffusion technique. J Microencapsul. 1998;15:107–19.
Carpenter JF, Pikal MJ, Chang BS, Randolph TW. Rational design of stable lyophilized protein formulations: some practical advice. Pharm Res. 1997;14:969–75.
Adams GDJ, Ramsay JR. Optimizing the lyophilization cycle and the consequences of collapse on the pharmaceutical acceptability of Erwinia l-asparaginase. J Pharm Sci. 1996;85:1301–5.
Zambaux MF, Bonneaux F, Gref R, Dellacherie E, Vigneron C. MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties. J Biomed Mater Res. 1999;44:109–15.
Singh-Joy SD, McLain VC. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics. Int J Toxicol. 2008;27:93–128.
Millipore Corporation. Technical brief: protein concentration and diafiltration by tangential flow filtration. Billerica: Millipore Corporation; 2003.
Kokol V. Interactions between polysaccharide polymer thickener and bifunctional bireactive dye in the presence of nonionic surfactants. Part 1: surface tension and rheological behavior of different polysaccharide solutions. Carbohydr Polym. 2002;50:227–36.
Choi MJ, Briancon S, Andrieu J, Min SG, Fessi H. Effect of freeze-drying process conditions on the stability of nanoparticles. Dry Technol. 2004;22:335–46.
Acknowledgements
The Electron Microscopy Unit of the Institute of Biotechnology (University of Helsinki) is acknowledged for providing laboratory facilities and analytical equipment.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hirsjärvi, S., Peltonen, L. & Hirvonen, J. Effect of Sugars, Surfactant, and Tangential Flow Filtration on the Freeze-Drying of Poly(lactic acid) Nanoparticles. AAPS PharmSciTech 10, 488–494 (2009). https://doi.org/10.1208/s12249-009-9236-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-009-9236-z